Search results: Sage Journals

Restricted accessResearch articleFirst published March 21, 2017

Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy

Eric Heuer, Jessica Jacobs, Rebecca Du [...]

Journal of Alzheimer’s Disease

Open accessCase reportFirst published 2023

Acute cholangitis following mRNA COVID-19 vaccine booster in a patient receiving an anti-amyloid antibody for Alzheimer’s disease: A case report

Linda L Restifo, Robert P Erickson

Sage Open Medical Case Reports

Restricted accessResearch articleFirst published March 21, 2017

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients

Nzeera Ketter, H. Robert Brashear, Jennifer Bogert [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published December 12, 2018

Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies

H. Robert Brashear, Nzeera Ketter, Jennifer Bogert [...]

Journal of Alzheimer’s Disease

Restricted accessReview articleFirst published 2026

Comparative risk of amyloid-related imaging abnormalities with anti–amyloid-β monoclonal antibodies: A systematic review and penalized likelihood network meta-analysis of randomized trials

Arkansh Sharma, Vinay Suresh, Pavan Raju Kola [...]

Journal of Alzheimer’s Disease

Restricted accessBrief reportFirst published October 8, 2024

Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value

Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published October, 2025

Reducing ARIA risk in Alzheimer's disease: Real-world impact of APOE genotype-guided slow titration with aducanumab and lecanemab

Nicholas Mervosh, Nadir Bilici, Thomas Wisniewski [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published August 14, 2017

Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPP swe Mice Without Inducing Microhemorrhage

Stephanie Villarreal, Fuqiang Zhao, Lynn A. Hyde [...]

Journal of Alzheimer’s Disease

Open accessArticle commentaryFirst published 2026

Amyloid-related imaging abnormalities after immunotherapy: How might brain microvascular basement membrane components be involved?

Harry V. Vinters, Shino Magaki

Journal of Alzheimer’s Disease

Restricted accessReview articleFirst published February, 2026

Severe symptomatic amyloid-related imaging abnormalities in Alzheimer's disease: Two case reports and systematic review of reported cases

Alberto Villarejo Galende, Marta González-Sánchez, Amaya Hilario [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published March 21, 2017

Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy

Eric Heuer, Jessica Jacobs, Rebecca Du [...]

Journal of Alzheimer’s Disease

Open accessCase reportFirst published 2023

Acute cholangitis following mRNA COVID-19 vaccine booster in a patient receiving an anti-amyloid antibody for Alzheimer’s disease: A case report

Linda L Restifo, Robert P Erickson

Sage Open Medical Case Reports

Restricted accessResearch articleFirst published March 21, 2017

Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer’s Disease Patients

Nzeera Ketter, H. Robert Brashear, Jennifer Bogert [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published December 12, 2018

Clinical Evaluation of Amyloid-Related Imaging Abnormalities in Bapineuzumab Phase III Studies

H. Robert Brashear, Nzeera Ketter, Jennifer Bogert [...]

Journal of Alzheimer’s Disease

Restricted accessReview articleFirst published 2026

Comparative risk of amyloid-related imaging abnormalities with anti–amyloid-β monoclonal antibodies: A systematic review and penalized likelihood network meta-analysis of randomized trials

Arkansh Sharma, Vinay Suresh, Pavan Raju Kola [...]

Journal of Alzheimer’s Disease

Restricted accessBrief reportFirst published October 8, 2024

Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value

Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published October, 2025

Reducing ARIA risk in Alzheimer's disease: Real-world impact of APOE genotype-guided slow titration with aducanumab and lecanemab

Nicholas Mervosh, Nadir Bilici, Thomas Wisniewski [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published August 14, 2017

Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPP swe Mice Without Inducing Microhemorrhage

Stephanie Villarreal, Fuqiang Zhao, Lynn A. Hyde [...]

Journal of Alzheimer’s Disease

Open accessArticle commentaryFirst published 2026

Amyloid-related imaging abnormalities after immunotherapy: How might brain microvascular basement membrane components be involved?

Harry V. Vinters, Shino Magaki

Journal of Alzheimer’s Disease

Restricted accessReview articleFirst published February, 2026

Severe symptomatic amyloid-related imaging abnormalities in Alzheimer's disease: Two case reports and systematic review of reported cases

Alberto Villarejo Galende, Marta González-Sánchez, Amaya Hilario [...]

Journal of Alzheimer’s Disease